Redeye slightly overestimated the Coronavirus effect on Doro's Q2 earnings. Nevertheless, our overall impression is that the quarter was weak due to a zero growth in Care, following 10 000 lost subscriptions since Q1'20. However, we are not looking to make any major revisions based on the earnings results in Q2.